Table 1 Baseline characteristics between survivors and non-survivors

Age, M (Q₁, Q₃)

58.00

(51.00, 65.00)

57.00

(50.00, 63.00)

69.00

(61.00, 76.00)

Z=-34.36

< 0.001

Male, n(%)

4742 (46.40)

3891 (44.22)

851 (59.89)

χ²=120.74

< 0.001

Married, n(%)

8999 (88.05)

7954 (90.40)

1045 (73.54)

χ²=330.46

< 0.001

Smoking history, n(%)

3990 (39.04)

3243 (36.86)

747 (52.57)

χ²=126.91

< 0.001

Alcohol history, n(%)

3960 (38.75)

3301 (37.52)

659 (46.38)

χ²=40.47

< 0.001

Hypertension, n(%)

2735 (26.76)

2217 (25.20)

518 (36.45)

χ²=79.10

< 0.001

Diabetes, n(%)

617 (6.04)

483 (5.49)

134 (9.43)

χ²=33.49

< 0.001

Lung disease, n(%)

987 (9.66)

725 (8.24)

262 (18.44)

χ²=145.83

< 0.001

Kidney disease, n(%)

577 (5.65)

476 (5.41)

101 (7.11)

χ²=6.62

< 0.001

Heart disease, n(%)

1225 (11.99)

986 (11.21)

239 (16.82)

χ²=36.54

< 0.001

FBG, M (Q₁, Q₃)

102.42

(94.32, 113.40)

102.06

(94.14, 112.50)

104.40

(94.68, 118.98)

Z=-5.14

< 0.001

HbA1c, M (Q₁, Q₃)

5.10

(4.90, 5.40)

5.10

(4.90, 5.40)

5.10

(4.90, 5.50)

Z=-1.53

0.125

Cholesterol,

M (Q₁, Q₃)

189.82

(166.62, 214.95)

190.21

(167.40, 215.14)

186.73

(160.83, 214.95)

Z=-3.18

0.001

TG, M (Q₁, Q₃)

105.32

(75.22, 155.76)

106.20

(75.22, 156.65)

102.66

(72.57, 149.57)

Z=-3.03

0.002

HDL, M (Q₁, Q₃)

49.29

(40.21, 59.92)

49.10

(40.21, 59.54)

50.26

(40.21, 61.47)

Z=-2.13

0.033

LDL, M (Q₁, Q₃)

114.05

(92.78, 136.86)

114.43

(93.56, 137.24)

110.18

(87.76, 134.54)

Z=-4.28

< 0.001

Stroke, n(%)

271 (2.65)

185 (2.10)

86 (6.05)

χ²=73.93

< 0.001

AIP, M (Q₁, Q₃)

0.75(0.28, 1.29)

0.76(0.29, 1.29)

0.68 (0.22, 1.22)

Z=-3.06

0.002

Tyg, M (Q₁, Q₃)

8.60(8.23, 9.06)

8.60(8.23, 9.06)

8.61 (8.20, 9.06)

Z=-0.23

0.822